TWP
BSX icon

Triad Wealth Partners’s Boston Scientific BSX Stock Holding History

Triad Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
+5,124
New +$278K 0.01% 486
2024
Q3 		– Sell
-333
Closed -$25.6K – 173
2024
Q2 		$25.6K Buy
+333
New +$24.4K 0.01% 309

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Triad Wealth Partners's BSX Position: Q2 2026 in Review

Triad Wealth Partners opened a new position in Boston Scientific (BSX) in Q2 2026: 5,124 shares worth $248K. The stake represents 0.01% of the portfolio and ranks #486 among its holdings. This is a return to the name: Triad Wealth Partners previously reported a position in BSX as recently as Q2 2024.

Triad Wealth Partners first reported a position in BSX in Q2 2024 and has held it in 2 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Triad Wealth Partners held 5,124 shares of Boston Scientific worth $248K as of Q2 2026.
  • Boston Scientific was a new Triad Wealth Partners position in Q2 2026.
  • Boston Scientific made up 0.01% of Triad Wealth Partners's portfolio in Q2 2026, its #486 holding.
  • Triad Wealth Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 2 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Triad Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.